Nanoparticle-Mediated Rescue of p53 Through Targeted Degradation of MDM2
Abstract
The interaction between MDM2 and p53 is a viable therapeutic target as overexpression of MDM2 can lead to excessive p53 degradation suppressing a cell's ability to cope with cellular insult. The goal of this research is to use recent advances in nanotechnology to develop a specific nanoparticle antagonist to disrupt the MDM2:p53 interaction. Inhibiting the interaction between p53 and MDM2 allows wild-type p53 concentrations to rise to functional levels effectively killing proliferating tumor cells. By incorporating traditional peptide inhibitors of MDM2 with mixed-monolayer protected gold cluster nanoparticles we hope to effect MDM2 denaturation on the nanoparticle surface increase peptide stability and facilitate intracellular peptide delivery. Nanoparticle characteristics such as size surface chemistry and biocompatibility may be controlled and modified for these specific applications. Our findings demonstrated that nanoparticles decorated with inhibitory peptides can be used to inhibit the MDM2:p53 interaction. Further optimization of the nanoparticles is required for successful implementation in therapeutic applications.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2006
- Accession Number
- ADA463828
Entities
People
- Nicholas O. Fischer
Organizations
- University of Massachusetts Amherst